Kazutaka Miyadera, PhD
Articles
UFT and Its Metabolites Inhibit Cancer-Induced Angiogenesis via a VEGF - Related Pathway
Yuji Basaki, MSC;Lumi Chikahisa, MSC;Kazutaka Miyadera, PhD;Jiro Shibata, MSC;Konstanty Wierzba, PhD;Yuji Yamada, PhD
October 1st 2000Treatment with UFT for spontaneous lung metastasis of murine renal carcinoma (RENCA) after resection of the primary tumor has resulted in significant prolongation of the life span of tumor-bearing animals. UFT inhibited the growth of metastatic nodules in the lung, apparently via decreased density of microvessels in the metastatic foci. Subsequent experiments used dorsal air sac assay to directly trace newly forming microvessels.
Latest Updated Articles
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: May 1st 2015 | Updated: November 22nd 2024
Neutropenia and Abdominal Pain in a 30-Year-Old Patient
Published: August 19th 2019 | Updated: November 22nd 2024
A 22-Year-Old Woman With Pain, Tenderness and Swelling in the Breast
Published: July 29th 2015 | Updated: November 22nd 2024
Liver Abnormality in 28-Year-Old Patient
